Tumor Mutational Burden Predicts Progression-Free Survival and Local-Regional Control in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Durvalumab. - Shaverdian, N.; Shepherd, A.F.; Offin, M.; Gelblum, D.; Wu, A.J.; Simone II, C.B.; Schoenfeld, A.J.; Jones, D.; Rimner, A.; Chaft, J.; Riaz, N.; Gomez, D.R. (International Journal of Radiation Oncology, Biology, Physics, 2022)